Unilife (UNIS -5.5%) takes a hit this morning despite beating FQ2 bottom line estimates late...

|About: Unilife Corporation (UNIS)|By:, SA News Editor

Unilife (UNIS -5.5%) takes a hit this morning despite beating FQ2 bottom line estimates late yesterday. The developer and commercial supplier of injectable drug delivery systems reported an adjusted Q2 loss of $0.12 per share, versus the $0.13 loss per share that analysts were expecting, but revenues came in at just $700K compared with $900K for the same period last year, and below the Street view of $2.01M.